Seer appoints Anthony Bazarko as Chief Commercial Officer to boost growth and adoption of Proteograph® suite

Seer, Inc. has named Anthony Bazarko as its new Chief Commercial Officer. Bazarko brings over 20 years of experience in life sciences and biotechnology, having held leadership roles at Biologos, Specific Diagnostics, Danaher, and Roche Diagnostics. He will lead Seer's sales, marketing, and customer experience teams to accelerate the growth and adoption of Seer's Proteograph® Product Suite, a cutting-edge proteomics platform. This move aims to strengthen Seer's commercial execution and expand global access to its technology for advanced proteomic research.